+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genetic Testing Market - Global Forecast 2026-2032- Product Image
Genetic Testing Market - Global Forecast 2026-2032- Product Image
Sale

Genetic Testing Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904587
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Genetic Testing Market is projected to reach USD 17.60 Billion in 2026. It is expected to continue growing at a CAGR of 14.44%, reaching USD 39.72 Billion by 2032.

The genetic testing market is moving from specialized diagnostics into mainstream healthcare as next-generation sequencing, PCR-based assays, microarrays, and targeted panels support earlier disease detection, precision medicine, carrier screening, pharmacogenomics, and oncology companion diagnostics. The National Human Genome Research Institute has documented a dramatic decline in sequencing costs since the Human Genome Project, enabling broader clinical use of genomic testing across hospitals, reference laboratories, and direct-to-consumer channels.

Demand is being reinforced by the rising burden of cancer, rare diseases, inherited cardiovascular conditions, reproductive health needs, and medication-response variability. Clinically validated genetic tests are increasingly embedded in care pathways, while regulators, payers, and health systems are emphasizing analytical validity, clinical validity, informed consent, data privacy, and equitable access.

Transformative Shifts in the Genetic Testing Landscape

The landscape is being reshaped by the shift from single-gene testing to multi-gene panels, whole-exome sequencing, and whole-genome sequencing. Oncology remains a central growth engine as tumor profiling and germline testing guide targeted therapies, immunotherapy eligibility, and hereditary cancer risk management. The U.S. FDA’s authorization of next-generation sequencing companion diagnostics has helped normalize genomic evidence in drug selection.

At the same time, reproductive genetics, non-invasive prenatal screening, newborn sequencing research, and pharmacogenomics are expanding the clinical scope of genetic testing. The market is also adapting to stricter oversight, including the EU In Vitro Diagnostic Regulation and ongoing scrutiny of laboratory-developed tests, which is pushing providers toward stronger quality systems, post-market evidence, and transparent clinical utility documentation.

Cumulative Impact of Artificial Intelligence on Genetic Testing

Artificial intelligence is accelerating genetic testing by improving variant calling, annotation, phenotype matching, laboratory workflow automation, and clinical report generation. AI-enabled bioinformatics can help prioritize variants of uncertain significance, cross-reference genomic findings with curated databases such as ClinVar, and support more efficient interpretation in rare disease and oncology settings.

The impact is cumulative rather than isolated: better algorithms increase throughput, richer datasets improve model performance, and digital reporting strengthens clinician adoption. However, responsible deployment requires explainability, validation across diverse populations, bias monitoring, cybersecurity, human expert review, and compliance with privacy frameworks such as HIPAA, GDPR, and relevant national genomics regulations.

Key Regional Insights for Genetic Testing

North America leads in clinical adoption due to established reference laboratories, oncology testing infrastructure, FDA-cleared genomic diagnostics, CLIA-regulated laboratory practices, NIH-supported genomics research, and payer coverage for selected hereditary cancer, prenatal, rare disease, and tumor profiling tests. Europe is advancing through national genomics programs, the NHS Genomic Medicine Service, France’s genomic medicine initiatives, Germany’s precision oncology activity, and strong data protection under GDPR, while the EU IVDR is raising the compliance threshold for in vitro diagnostics.

Asia-Pacific is scaling rapidly as Japan, China, South Korea, India, and Australia expand precision medicine, population genomics, newborn and rare disease initiatives, and cancer testing capacity. Latin America, led by Brazil and Mexico, is increasing access through private laboratories, academic hospitals, and oncology centers, though reimbursement and specialist availability remain uneven. The Middle East is notable for national genome programs and premarital screening policies in the GCC, while Africa is building genomic capacity through research networks, infectious disease sequencing, and public health genomics initiatives despite infrastructure, workforce, and funding constraints.

Key Group Insights Across Global Genetic Testing Markets

ASEAN presents a diverse adoption profile, with Singapore supporting advanced genomics, precision medicine, and biomedical research while neighboring markets expand prenatal, oncology, and infectious disease-related molecular diagnostics as healthcare investment rises. The GCC is prioritizing population-scale genome programs, premarital screening, newborn screening, and inherited disease detection, supported by government-led precision medicine strategies in the United Arab Emirates, Qatar, and Saudi Arabia.

The European Union is defined by harmonized data protection under GDPR, increasing diagnostic regulation under IVDR, national genomic medicine investments, and cross-border research collaboration. BRICS countries offer scale through large populations, national genomics initiatives, and growing local sequencing capacity, although reimbursement, laboratory accreditation, and data governance vary. G7 countries remain influential in clinical standards, reimbursement evidence, rare disease policy, and guideline development, while NATO members create demand around secure health data infrastructure, biosecurity readiness, resilient diagnostics supply chains, and interoperable laboratory systems.

Key Country Insights for Genetic Testing

The United States remains the largest innovation hub, supported by major clinical laboratories, cancer centers, NIH-funded genomics research, CLIA laboratory regulation, and FDA oversight of companion diagnostics. Canada emphasizes publicly funded healthcare integration, provincial coverage decisions, newborn screening, and cancer genetics programs, while Mexico is expanding private-sector genetic testing and oncology diagnostics. Brazil leads much of Latin America’s precision medicine activity, especially in hereditary cancer, reproductive genetics, and prenatal testing.

The United Kingdom benefits from the NHS Genomic Medicine Service and lessons from the 100,000 Genomes Project. Germany, France, Italy, and Spain are advancing genomic medicine through national and regional programs, oncology networks, and rare disease initiatives, while Russia maintains interest in genetics research and domestic testing capacity. China is advancing population genomics, oncology testing, and sequencing infrastructure; India is expanding genetic testing for rare diseases, reproductive health, and cancer through major urban centers; Japan combines precision oncology, pharmacogenomics, and aging-related healthcare priorities; Australia supports clinical genomics through national research and healthcare initiatives; and South Korea is strengthening cancer profiling, clinical sequencing, and digital health integration.

Actionable Recommendations for Genetic Testing Leaders

Industry leaders should prioritize clinically validated, guideline-aligned tests in high-value areas such as oncology, hereditary cancer, rare disease, reproductive health, newborn screening, and pharmacogenomics. Building payer-ready evidence through real-world outcomes, health economics, analytical validation, and clinical utility studies is essential for broader reimbursement and physician adoption.

Organizations should also invest in AI-enabled bioinformatics, interoperable reporting, genetic counseling support, secure cloud infrastructure, and laboratory quality management while maintaining rigorous compliance standards. Partnerships with hospitals, pharmaceutical developers, population genomics programs, public health agencies, and academic centers can accelerate data access and validation. To improve equity, leaders should expand reference datasets beyond European ancestry, strengthen informed consent processes, and design affordable testing models for underserved populations.

Research Methodology

This executive summary is developed using a secondary research methodology aligned with established industry research standards, drawing on verified sources such as regulatory publications, public health agencies, peer-reviewed literature, clinical guideline bodies, national genomics programs, and recognized healthcare disclosures. Market interpretation emphasizes documented adoption drivers, reimbursement trends, regulatory changes, and technology developments in genetic testing.

The analysis triangulates evidence across clinical application areas, technology platforms, end-user demand, regional policy environments, and competitive activity. Findings are validated by comparing information from multiple credible sources and excluding unsupported claims, market sizing, market share, or forecasting. The methodology prioritizes analytical validity, clinical utility, regulatory relevance, data governance, and measurable healthcare impact.

Conclusion

Genetic testing is becoming a foundational pillar of precision healthcare, with validated genomic insights improving diagnosis, prevention, treatment selection, reproductive planning, and family risk assessment. Falling sequencing costs, stronger clinical evidence, expanded oncology use, and digital bioinformatics are pushing genetic testing from specialized use toward routine care.

Future progress will depend on reimbursement clarity, ethical data governance, clinician education, genetic counseling capacity, diverse genomic datasets, and scalable laboratory quality. Organizations that combine scientific rigor with accessible delivery models, AI-enabled interpretation, and privacy-first infrastructure will be best positioned to lead the next phase of the global genetic testing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Genetic Testing Market, by Offering
7.1. Introduction
7.2. Instruments
7.2.1. Sequencers
7.2.2. PCR Systems
7.2.3. Microarray Scanners
7.3. Software & Informatics
7.3.1. Variant interpretation
7.3.2. Clinical decision support
7.3.3. Bioinformatics
7.4. Services
7.4.1. Consulting
7.4.2. Maintenance & Support
7.5. Reagents & Consumables
8. Genetic Testing Market, by Test Type
8.1. Introduction
8.2. Carrier Testing
8.3. Diagnostic Testing
8.4. New Born Screening
8.5. Pharmacogenomics
8.6. Preimplantation Testing
8.7. Prenatal Testing
8.8. Presymptomatic & Predictive Testing
9. Genetic Testing Market, by Technology
9.1. Introduction
9.2. Cytogenetics
9.3. DNA Sequencing
9.4. Gene Expression Profiling
9.5. Microarrays
9.6. Polymerase Chain Reaction (PCR)
10. Genetic Testing Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Saliva
10.4. Tissue
10.5. Buccal swab
11. Genetic Testing Market, by Application
11.1. Introduction
11.2. Autoimmune Disorders
11.3. Oncology
11.4. Chronic Diseases
11.5. Genetic Disorders
11.6. Neurodegenerative Diseases
12. Genetic Testing Market, by End-User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Home Setting
12.4. Hospitals & Clinics
13. Genetic Testing Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. Genetic Testing Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Genetic Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Genetic Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Agilent Technologies, Inc.
18.3. Becton, Dickinson and Company
18.4. BGI Genomics
18.5. Bio-Rad Laboratories, Inc.
18.6. Bio-Techne Corporation
18.7. Bruker Corporation
18.8. CooperSurgical Inc.
18.9. Eurofins Scientific SE
18.10. F. Hoffmann-La Roche AG
18.11. GeneDx, LLC
18.12. Guardant Health Inc.
18.13. Illumina, Inc.
18.14. Invitae Corporation
18.15. Laboratory Corporation of America Holdings
18.16. Myriad Genetics, Inc.
18.17. Natera, Inc.
18.18. Newtopia Inc.
18.19. PathogenDx Corporation
18.20. PerkinElmer Inc.
18.21. Qiagen N.V.
18.22. Quest Diagnostics Incorporated
18.23. Revvity Inc.
18.24. Sanofi S.A.
18.25. Sonic Healthcare
18.26. Tempus AI, Inc.
18.27. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL GENETIC TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL GENETIC TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL GENETIC TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL GENETIC TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL VARIANT INTERPRETATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL VARIANT INTERPRETATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL VARIANT INTERPRETATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CONSULTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CONSULTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CONSULTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CARRIER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CARRIER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CARRIER TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NEW BORN SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NEW BORN SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NEW BORN SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PREIMPLANTATION TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PREIMPLANTATION TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PREIMPLANTATION TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PRENATAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PRENATAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PRESYMPTOMATIC & PREDICTIVE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PRESYMPTOMATIC & PREDICTIVE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PRESYMPTOMATIC & PREDICTIVE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CYTOGENETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CYTOGENETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CYTOGENETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MICROARRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MICROARRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL MICROARRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BUCCAL SWAB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BUCCAL SWAB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BUCCAL SWAB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL AUTOIMMUNE DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL AUTOIMMUNE DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL AUTOIMMUNE DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CHRONIC DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CHRONIC DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CHRONIC DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL GENETIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL GENETIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL NEURODEGENERATIVE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL NEURODEGENERATIVE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL NEURODEGENERATIVE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL HOME SETTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL HOME SETTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HOME SETTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 158. EUROPE GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. EUROPE GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 160. EUROPE GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 161. EUROPE GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 162. EUROPE GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 163. EUROPE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 164. EUROPE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 165. EUROPE GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 166. EUROPE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. EUROPE GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 168. EUROPE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 180. AFRICA GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. AFRICA GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 182. AFRICA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 183. AFRICA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 184. AFRICA GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 185. AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 186. AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 187. AFRICA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 188. AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 190. AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. ASEAN GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. ASEAN GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 194. ASEAN GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 195. ASEAN GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 196. ASEAN GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 197. ASEAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 198. ASEAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 199. ASEAN GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 200. ASEAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. ASEAN GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 202. ASEAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 203. GCC GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. GCC GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 205. GCC GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 206. GCC GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 207. GCC GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 208. GCC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 209. GCC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. GCC GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 211. GCC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. GCC GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 213. GCC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 225. BRICS GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. BRICS GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 227. BRICS GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 228. BRICS GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 229. BRICS GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 230. BRICS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 231. BRICS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 232. BRICS GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 233. BRICS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. BRICS GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 235. BRICS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 236. G7 GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. G7 GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 238. G7 GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 239. G7 GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 240. G7 GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 241. G7 GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 242. G7 GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 243. G7 GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 244. G7 GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. G7 GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 246. G7 GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. NATO GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. NATO GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 249. NATO GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 250. NATO GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 251. NATO GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 252. NATO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 253. NATO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 254. NATO GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 255. NATO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. NATO GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 257. NATO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 258. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. CANADA GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. CANADA GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 272. CANADA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 273. CANADA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 274. CANADA GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 275. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 276. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 277. CANADA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 278. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 280. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 281. MEXICO GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. MEXICO GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 283. MEXICO GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 284. MEXICO GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 285. MEXICO GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 286. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 287. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 288. MEXICO GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 289. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 291. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. BRAZIL GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 294. BRAZIL GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 295. BRAZIL GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 303. UNITED KINGDOM GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 305. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 306. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 307. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 314. GERMANY GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. GERMANY GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 316. GERMANY GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 317. GERMANY GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 318. GERMANY GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 319. GERMANY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 320. GERMANY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 321. GERMANY GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 322. GERMANY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 323. GERMANY GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 324. GERMANY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 325. FRANCE GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. FRANCE GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 327. FRANCE GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 328. FRANCE GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 329. FRANCE GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 330. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 331. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 332. FRANCE GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 333. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 334. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 335. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. RUSSIA GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. RUSSIA GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 338. RUSSIA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 339. RUSSIA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 340. RUSSIA GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 341. RUSSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 342. RUSSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 343. RUSSIA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 344. RUSSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 345. RUSSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 346. RUSSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 347. ITALY GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. ITALY GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 349. ITALY GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 350. ITALY GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 351. ITALY GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 352. ITALY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 353. ITALY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 354. ITALY GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 355. ITALY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 356. ITALY GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 357. ITALY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 358. SPAIN GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 359. SPAIN GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 360. SPAIN GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 361. SPAIN GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 362. SPAIN GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 363. SPAIN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 364. SPAIN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 365. SPAIN GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 366. SPAIN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 367. SPAIN GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 368. SPAIN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 369. CHINA GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 370. CHINA GENETIC TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 371. CHINA GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 372. CHINA GENETIC TESTING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 373. CHINA GENETIC TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 374. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 375. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 376. CHINA GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 377. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 378. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 379. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 380. INDIA GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TAB

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • CooperSurgical Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GeneDx, LLC
  • Guardant Health Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Newtopia Inc.
  • PathogenDx Corporation
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Revvity Inc.
  • Sanofi S.A.
  • Sonic Healthcare
  • Tempus AI, Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 17.6 Billion
Forecasted Market Value ( USD ) by 2032 $ 39.72 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Rare Disease Genetic Testing Market - Global Forecast 2026-2032 - Product Image

Rare Disease Genetic Testing Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Preimplantation Genetic Testing Market - Global Forecast 2026-2032 - Product Image

Preimplantation Genetic Testing Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report - Product Image

Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report

  • Report
  • 267 Pages
  • Global
From
Preimplantation Genetic Testing - Global Strategic Business Report - Product Image

Preimplantation Genetic Testing - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
Genetic Testing Market Size, Share, Trends and Forecast by Type, Technology, Application, and Region, 2026-2034 - Product Image

Genetic Testing Market Size, Share, Trends and Forecast by Type, Technology, Application, and Region, 2026-2034

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.